Cardiac Output Measurement in Pediatric Intensive Care Unit by Metabolic Monitor (Fick Method) (PEDIA-FICK-ICU)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Fick's method, Echocardiography.
- Who it may be relevant to
- Registry conditions: Intensive Care Units, Pediatric. Basic parameters: 28 Days — 17 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Cardiac Output Measurement in Pediatric Intensive Care Unit by Metabolic Monitor (Fick Method) : Prospective Feasibility Study
Overview
Cardiac output measurement is one of the most frequently used haemodynamic parameter used for intensive care unit (ICU) patients. In pediatric ICU, it is often measured with echocardiography that is a non-invasive method but is operator dependant and can't provide continuous monitoring. The goal of this clinical trial is to evaluate the feasibility of cardiac output measurement by Fick's method, non-invasive and allowing continuous monitoring, in comparison to echocardiography in pediatric intensive care unit.
Interventions
- Diagnostic test Fick's method
Cardiac output measurement by Fick method - Diagnostic test Echocardiography
Cardiac output measurement by echocardiography
Primary outcome measures
- Intra-class correlation (or concordance) between the measurement of cardiac output (in ml/min) by Fick's method and by echocardiography [Time frame: Up to day 3]
Secondary outcome measures (3)
- Variations of cardiac output before and after Leg Raise Test [Time frame: Up to day 3]
- Adverse events on the day of catheterization [Time frame: Up to 21 days]
- Adverse events on the day of catheter removal [Time frame: Up to 21 days]
Eligibility criteria
Inclusion criteria
- Patient under 18 years old
- Patient over 10 kg
- Patient requiring intubation or intubated with a cuffed tube
- Patient requiring a central venous line in superior vena cava territory
Exclusion criteria
- Mechanical ventilation with leak
- Bad echogenicity preventing echocardiography
- Absence of written informed consent
- Patient not affiliated to French Health Insurance or not covered by public health insurance
- Patient with a legal protection
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
France · 1 center
- UH Montpellier — Montpellier
Identifiers
NCT: NCT05741918 · RECHMPL22_0227